HUM Trading Analysis - 08/24/2026 12:08 PM โ€” TRU-SENTIMENT

HUM (Humana Inc.) at $382.61. True Sentiment Bearish, delta 40-60 call 21% / put 79%, call $80,962 vs put $301,309. RSI 63.5.

TRU-SENTIMENT ยท DeltaNeutral

HUM Trading Analysis - 08/24/2026 12:08 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

HUM (Humana Inc.) at $382.61. True Sentiment Bearish, delta 40-60 call 21% / put 79%, call $80,962 vs put $301,309. RSI 63.5.

Symbol
HUM
Price
$382.61
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-08-24 12:08:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

The options flow sentiment for HUM is currently Bearish, with the following details:

  • Call Dollar Volume: $80,961.50 (21.2%)
  • Put Dollar Volume: $301,309.00 (78.8%)
  • Total Dollar Volume: $382,270.50

This indicates a strong preference for puts over calls, suggesting bearish sentiment among options traders. The divergence between the bullish technical indicators and bearish options sentiment could imply caution in entering new positions.

Key Statistics: HUM

$378.88 +0.00%
52-Week Range
$163.11 - $428.88
Market Cap
$137.37B
P/E (TTM)
35.78
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$1.74M
Dividend Yield
N/A

Fundamental Snapshot

Valuation

P/E (Trailing)35.78
P/E (Forward)N/A
PEG RatioN/A
Price/Book7.13

Profitability

EPS (Trailing)$10.59
EPS (Forward)N/A
ROE6.72%
Net Margin0.89%

Financial Health

Revenue (TTM)$145.68B
Debt/Equity1.97
Free Cash FlowN/A
Rev GrowthN/A

Analyst Consensus

None
Target: $N/A
Based on None Analysts

๐Ÿ“ˆ Analysis

News Headlines & Context:

Recent headlines surrounding HUM include:

  • HUM reports strong quarterly earnings, beating analyst expectations.
  • Company announces new strategic partnership aimed at expanding market reach.
  • Analysts raise price targets following positive earnings report.
  • Concerns over regulatory changes impacting healthcare sector.
  • Market reacts to broader economic indicators affecting healthcare stocks.

These headlines indicate a mix of positive earnings momentum and strategic growth initiatives, which could support bullish sentiment. However, regulatory concerns may introduce volatility, impacting the stock's technical performance.

Fundamental Analysis:

The fundamentals for HUM indicate a strong financial position:

  • Total Revenue: $145.68 billion
  • Trailing EPS: $10.59
  • Trailing P/E Ratio: 35.78
  • Debt to Equity Ratio: 1.97
  • Return on Equity (ROE): 6.72%
  • Operating Margin: 1.86%
  • Profit Margin: 0.89%

While the P/E ratio suggests HUM may be overvalued compared to peers, the revenue and earnings figures indicate solid performance. The high debt-to-equity ratio raises concerns about financial leverage, but the operating cash flow of $2.54 billion provides a cushion. Overall, the fundamentals align with a bullish technical picture, although the debt level warrants caution.

Current Market Position:

As of the latest data, HUM's current price is $384.00, with recent price action showing fluctuations around this level. The key support and resistance levels are:

Support
$375.00
Resistance
$390.00
Entry
$378.50
Target
$395.00
Stop Loss
$370.00

Intraday momentum shows fluctuations with a recent high of $389.85 and a low of $379.27, indicating a consolidation phase.

Technical Analysis:

Technical Indicators

RSI (14)
63.47
MACD
Bullish
50-day SMA
$383.56

The SMA trends show the 5-day SMA at $380.73, the 20-day SMA at $377.33, and the 50-day SMA at $383.56. The price is currently above the 50-day SMA, indicating bullish momentum. The RSI at 63.47 suggests that the stock is nearing overbought territory, while the MACD indicates a bullish signal. The Bollinger Bands show the price is approaching the upper band at $395.75, indicating potential resistance ahead.

True Sentiment Analysis (Delta 40-60 Options):

The options flow sentiment for HUM is currently Bearish, with the following details:

This indicates a strong preference for puts over calls, suggesting bearish sentiment among options traders. The divergence between the bullish technical indicators and bearish options sentiment could imply caution in entering new positions.

Key Price Levels (Observational Only):

Key price levels to observe include:

Support
$375.00
Resistance
$390.00

These levels will be critical in confirming or invalidating the bearish sentiment observed in options flow.

25-Day Price Forecast:

Based on current trends, HUM is projected for $370.00 to $395.00. This projection considers the bullish indicators from the technical analysis, including the SMA trends and MACD signals, alongside the resistance levels identified. The ATR of $13.28 suggests moderate volatility, which could affect the price movement within this range.

Defined Risk Strategy Recommendations:

Given the projected price range of $370.00 to $395.00, the following defined risk strategies are recommended:

Each strategy aligns with the projected price range and offers defined risk while allowing for potential profit based on market movements.

Risk Factors:

Key risk factors include:

These factors could invalidate the bullish thesis if not monitored closely.

Summary & Conviction Level:

Overall, the bias for HUM is Bullish based on technical indicators, although caution is warranted due to bearish sentiment in options flow. The conviction level is medium due to the divergence between technicals and sentiment.

One-line trade idea: Monitor for alignment between technical indicators and options sentiment before making directional trades.

View HUM Options Chain
Bear Put Spread 380 375 380-375 Bear Put Spread at Expiration Stock Price at Expiration Profit Loss
Bull Call Spread 385 390 385-390 Bull Call Spread at Expiration Stock Price at Expiration Profit Loss

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.